Connection

Payam Tabarsi to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Payam Tabarsi has written about Injections, Subcutaneous.
Payam Tabarsi
Connection Strength
0.357
Injections, Subcutaneous
  1. Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102.
    View in: PubMed
    Score: 0.181
  2. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.